Effects of Electrical Stimulation on Osteoarthritis of the Knee

January 25, 2008 updated by: University of Virginia
The purpose of this study is to find out whether electrical stimulation can reduce knee pain and increase function in people with osteoarthritis of the knee.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Charlottesville, Virginia, United States, 22903
        • University of Virginia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 50 years of age or older
  • Diagnosis of primary osteoarthritis of the knee (as defined by American College of Rheumatology criteria)
  • Knee pain of at least six months duration
  • Moderate or greater knee pain (defined as a score of 3 or greater on an 11 point numeric pain rating scale) for most days in the last month
  • Willing to abide by protocol and treatment schedule.

Exclusion Criteria:

  • Implants, such as pacemaker, TENS, or insulin pump, incompatible with electrical stimulation
  • Uncontrolled concomitant disease affecting the knee, such as: rheumatoid arthritis, systemic lupus erythema, psoriatic arthritis
  • Pregnant or breast-feeding
  • Intra-articular corticosteroid or hyaluronic acid injection into the knee within 3 months preceding study
  • Arthroscopy of the knee within the past year
  • Significant injury to the knee within the past 6 months
  • Use of assistive devices other than a cane or knee brace
  • Disease of spine or other lower extremity joints of sufficient degree to affect assessment of the knee

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
20-30 minute device sessions on the following schedule: 3 times per week for 3 weeks, then 2 times per week for 3 weeks, then 1 time per week for 2 weeks.
Other Names:
  • Noninvasive Interactive Neurostimulation
Placebo Comparator: 2
20-30 minute device sessions on the following schedule: 3 times per week for 3 weeks, then 2 times per week for 3 weeks, then 1 time per week for 2 weeks.
Other Names:
  • Noninvasive Interactive Neurostimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Knee Pain
Time Frame: Baseline, Week 4, Week 8, and Week 12
Baseline, Week 4, Week 8, and Week 12

Secondary Outcome Measures

Outcome Measure
Time Frame
Knee function
Time Frame: Baseline, Week 4, Week 8, and Week 12
Baseline, Week 4, Week 8, and Week 12
Knee stiffness
Time Frame: Baseline, Week 4, Week 8, and Week 12
Baseline, Week 4, Week 8, and Week 12
Patient global assessment
Time Frame: Baseline, Week 4, Week 8, and Week 12
Baseline, Week 4, Week 8, and Week 12
Health-related quality of life
Time Frame: Baseline, Week 4, Week 8, and Week 12
Baseline, Week 4, Week 8, and Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ann G Taylor, RN, EdD, University of Virginia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2004

Primary Completion (Actual)

July 1, 2006

Study Completion (Actual)

July 1, 2006

Study Registration Dates

First Submitted

January 12, 2008

First Submitted That Met QC Criteria

January 25, 2008

First Posted (Estimate)

January 28, 2008

Study Record Updates

Last Update Posted (Estimate)

January 28, 2008

Last Update Submitted That Met QC Criteria

January 25, 2008

Last Verified

January 1, 2008

More Information

Terms related to this study

Other Study ID Numbers

  • HIC 11630

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on InterX 5000

Subscribe